Arno Joachim Gingele

Arno Joachim Gingele

Auto-generated profile, based on publicly available information

Arno Joachim Gingele

Department of Cardiology, Maastricht University Medical Centre+, Maastricht, The Netherlands

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 May 2023 in European Journal of Public Health
Verified
Journal Article
Open access
PDF file
BSBianca Steiner
Bianca Steiner
ANAnne Neumann
Anne Neumann
YPYannick Pelz
Yannick Pelz
CSChantal Ski
Chantal Ski
LHLoreena Hill
Loreena Hill
BZBettina Zippel-Schultz
Bettina Zippel-Schultz
Background: In Europe, more than 15 million people live with heart failure (HF). It imposes an enormous social, organizational and economic burden. As a reaction to impending impact on healthcare provision, different country-specific structures for HF-care have been established. The aim of this report is to provide an overview and compare the HF-care approaches of Germany, Ireland, the Netherlands and the UK, and to open the possibility of learning from each other’s experience. Methods: A mixed methods approach was implemented that included a literature analysis, interviews and questionnaires with HF-patients and caregivers, and expert interviews with representatives from healthcare, health service research and medical informatics. Results: The models of HF-care in all countries analyzed are based on the European Society of Cardiology guidelines for diagnosis and treatment of HF. Even though the HF-models differed in design and implementation in practice, key challenges were similar: (i) unequal distribution of care between urban and rural areas, (ii) long waiting times, (iii) unequal access to and provision of healthcare services, (iv) information and communication gaps and (v) inadequate implementation and financing of digital applications. Conclusion: Although promising approaches exist to structure and improve HF-care, across the four countries, implementation was reluctant to embrace novel methods. A lack of financial resources and insufficient digitalization making it difficult to adopt new concepts. Integration of HF-nurses seems to be an effective way of improving current models of HF-care. Digital solutions offer further opportunities to overcome communication and coordination gaps and to strengthen self-management skills.

2 February 2023 in Wiener klinische Wochenschrift
Verified
Journal Article
Open access
PDF file
AGArno Joachim Gingele
Arno Joachim Gingele
HAHesam Amin
Hesam Amin
AVAniek Vaassen
Aniek Vaassen
ISIvana Schnur
Ivana Schnur
CPCathy Pearl
Cathy Pearl
JBJosiane Boyne
Josiane Boyne
Summary: Background: Heart failure is a severe condition and telemedicine can improve the care of heart failure. Many patients are unable to use telemedicine applications due to visual impairment and limited health-related literacy. Avatar technology might help to overcome these limitations. Methods: A telemedicine application was combined with a nurse avatar and offered to heart failure outpatients for 3 months. System usability and patient satisfaction were evaluated monthly by the system usability score (maximum score=100) and the patient satisfaction scale (maximum score=50). Results: In total, 37 heart failure patients were enrolled. The mean system usability score after 1 month was 73 (standard deviation=24) and 72 (standard deviation=10) after 3 months of follow-up, which was not significantly different (p = 0.40). The mean patient satisfaction scale after 1 month was 42 (standard deviation=5) and 39 (standard deviation=8) after 3 months, which was not significantly different (p = 0.10). Conclusion: A nurse look-a-like avatar integrated into a telemedicine application was positively assessed by heart failure patients. Future studies are warranted to clarify the role of avatar technology in telemedicine.

14 August 2019 in Netherlands Heart Journal
Verified
Journal Article
Open access
PDF file
AGA. J. Gingele
A. J. Gingele
BRB. Ramaekers
B. Ramaekers
HRH. P. Brunner-La Rocca
H. P. Brunner-La Rocca
GWG. De Weerd
G. De Weerd
JKJ. Kragten
J. Kragten
CKC. Knackstedt
C. Knackstedt
Background Functional status and health-related quality of life (HRQoL) are important in patients with heart failure (HF). Little is known about the effect of telemonitoring on functional status and HRQoL in that population. Methods and results A total of 382 patients with HF (New York Heart Association class 2–4) were included in a randomised controlled trial to investigate the effect of tailored telemonitoring on improving HRQoL and functional status in HF patients. Randomisation was computer-generated with stratification per centre. At baseline and after 12 months, patients’ functional status was determined by metabolic equivalent scores (METS). HRQoL was measured with the EuroQol five dimensions questionnaire (EQ-5D), visual analogue scale (VAS) and Borg rating of perceived exertion scale (Borg). Additional outcome data included number of HF-related outpatient clinic visits and mortality. Telemonitoring was statistically significantly related to an increase in METS after 1 year (regression coefficient 0.318; p = 0.01). Telemonitoring did not improve Borg, EQ-5D or VAS scores after 1 year. EQ-5D [hazard ratio (HR) 0.20, 95% confidence interval (CI) 0.07–0.54], VAS (HR 0.98, 95% CI 0.96–0.99), Borg (HR 1.21, 95% CI 1.11–1.31) and METS (HR 0.73, 95% CI 0.58–0.93) at baseline were significantly associated with survival after 12 months. Conclusions Tailored telemonitoring stabilised the functional status of HF patients but did not improve HRQoL. Therefore, telemonitoring may help to prevent deterioration of exercise capacity in patients with HF. However, because our study is a reanalysis of a randomised controlled trial (RCT), this is considered hypothesis-generating and should be confirmed by adequately powered RCTs.

17 December 2017 in Journal of Telemedicine and Telecare
Verified
Journal Article
Closed access
AGArno J Gingele
Arno J Gingele
HRHanspeter Brunner-La Rocca
Hanspeter Brunner-La Rocca
BRBram Ramaekers
Bram Ramaekers
AGAnton Gorgels
Anton Gorgels
GWGerjan De Weerd
Gerjan De Weerd
JBJosiane Jj Boyne
Josiane Jj Boyne
Evidence suggests that telemonitoring decreases mortality and heart failure (HF)-related hospital admission in patients with HF. However, most studies follow their patients for only several months. Little is known about the long-term effects of telemonitoring after a period of application. In 2007, the TEHAF study was initiated to compare tailored telemonitoring with usual care with respect to time until first HF-related hospital admission. In total, 301 patients completed the study after a follow-up period of one year. No differences could be found in time to first HF-related admission between intervention and control groups. Here, we performed a retrospective analysis in order to investigate potential long-term effects of telemonitoring. The primary endpoint was time to first HF-related hospital admission. Secondary endpoints were, amongst others, all-cause mortality, hospital admission due to HF and days alive and out of hospital (DAOOH). Electronic files of all included patients were reviewed between October 2007 and September 2015. Mean follow-up duration was 1652 days (standard deviation: 1055 days). No significant difference in time to first HF-related hospital admission (log-rank test, p = 0.15), all-cause mortality (log-rank test, p = 0.43), or DAOOH (two-sample t-test, p = 0.87) could be found. However, patients that underwent telemonitoring had significantly fewer HF-related hospital admissions (incident rate ratio 0.54, 95% confidence interval 0.31–0.88). Telemonitoring did not significantly influence the long-term outcome in our study. Therefore, extending the follow-up period of telemonitoring studies in HF patients is probably not beneficial.

13 September 2021 in Journal of Telemedicine and Telecare
Verified
Journal Article
Closed access
PDF file
AGArno Joachim Gingele
Arno Joachim Gingele
LBLloyd Brandts
Lloyd Brandts
KVKjeld Vossen
Kjeld Vossen
CKChristian Knackstedt
Christian Knackstedt
JBJosiane Boyne
Josiane Boyne
HRHans-Peter Brunner-La Rocca
Hans-Peter Brunner-La Rocca
Introduction: Heart failure is a serious burden on health care systems due to frequent hospital admissions. Early recognition of outpatients at risk for clinical deterioration could prevent hospitalization. Still, the role of signs and symptoms in monitoring heart failure patients is not clear. The heart failure coach is a web-based telemonitoring application consisting of a 9-item questionnaire assessment of heart failure signs and symptoms and developed to identify outpatients at risk for clinical deterioration. If deterioration was suspected, patients were contacted by a heart failure nurse for further evaluation. Methods: Heart failure coach questionnaires completed between 2015 and 2018 were collected from 287 patients, completing 18,176 questionnaires. Adverse events were defined as all-cause mortality, heart failure- or cardiac-related hospital admission or emergency cardiac care visits within 30 days after completion of each questionnaire. Multilevel logistic regression analyses were performed to assess the association between the heart failure coach questionnaire items and the odds of an adverse event. Results: No association between dyspnea and adverse events was observed (odds ratio 1.02, 95% confidence interval 0.79–1.30). Peripheral edema (odds ratio 2.21, 95% confidence interval 1.58–3.11), persistent chest pain (odds 2.06, 95% confidence interval 1.19–3.58), anxiety about heart failure (odds ratio 2.12, 95% confidence interval 1.44–3.13), and extensive struggle to perform daily activities (odds ratio 2.23, 95% confidence interval 1.38–3.62) were significantly associated with adverse outcome. Discussion: Regular assessment of more than the classical signs and symptoms may be helpful to identify heart failure patients at risk for clinical deterioration and should be an integrated part of heart failure telemonitoring programs.

27 June 2025 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
AGArno Joachim Gingele
Arno Joachim Gingele
BSBianca Steiner
Bianca Steiner
BZBettina Zippel-Schultz
Bettina Zippel-Schultz
HRHans-Peter Brunner-La Rocca
Hans-Peter Brunner-La Rocca
Background: Heart failure (HF) is a significant global health challenge, requiring innovative management strategies like eHealth. However, the success of eHealth in managing HF heavily relies on patient adherence, an area currently not sufficiently investigated despite its critical role in ensuring the effectiveness of this approach. Objective: This review was initiated to gather evidence on adherence to eHealth devices among patients with HF. The goal was to survey the current state of adherence, pinpoint factors that promote successful engagement, and identify gaps needing further research. Methods: A scoping review was conducted to gather quantitative data on eHealth engagement from relevant clinical HF studies indexed in PubMed, CINAHL, and PsycINFO up to February 2025. Descriptive characteristics of the publications were extracted, and generalized mixed model analyses were used to identify eHealth characteristics affecting patient adherence. Results: Our analysis included 70 studies, primarily using noninvasive eHealth interventions with wearables (n=51), followed by wearables only (n=8), noninvasive eHealth interventions without wearables (n=6), invasive devices (n=3), and telephone support (n=2). The median number of patients per study was 49 (IQR 20‐139), and the median follow-up duration was 180 (IQR 84‐360) days. Variability in reporting and definitions of eHealth adherence was noted. In total, 20 studies assessed adherence trends, with 13 noting a decline, 6 observing no change, and 1 reporting an increase over time. Factors influencing adherence were explored in 29 studies; 7 indicated higher adherence with increasing patient age, 2 showed a negative correlation, and 9 detected no age-related differences. No gender differences were found in the 10 publications that reported on gender, and 9 studies found no association between adherence and the New York Heart Association classification, while 1 noted higher adherence in patients with more severe symptoms. In 35 (50%) studies, adherence was quantified as the percentage of mean days the intervention was used, yielding a median adherence rate of 78% (IQR 61%‐86%; range 31%‐98%). No significant correlations were found between adherence rates and the number of eHealth device users, type of intervention, follow-up duration, number of parameters monitored, or data collection frequency. Conclusions: Reporting and definitions of patient adherence in HF studies are incomplete and inconsistent. Trends indicate a decrease in eHealth use over time. Customizing devices to meet patient needs may help mitigate this issue. Future research should offer a more detailed description of adherence to pinpoint factors that enhance patient adherence with eHealth technologies.